A. Overview
- Toxins produced by various strains of bacteria
- Staphylococcus aureus
- Streptococcus pyogenes
- Ehrlichia chaffeensis
- These toxins stimulate T lymphocytes leading to activation
- Activated T lymphocytes produce cytokines in large quantities
- Production of large quantities of cytokines leads to symptoms
- Skin rash
- Endothelial dysfunction - including nitric oxide production
- Hypotension
- Capilary leak
- Sepsis Syndrome may ensue
B. Clinical Diseases
- Staphylococcal [9]
- Women <30 years using tampons at highest risk [3,5]
- Original descriptions in children with staphylococcal infections [4]
- Majority of cases of TSS had vaginal cultures positive for staphylococcus
- May occur with staphylococcal infections at other sites, often occult
- Causative staphylococcal strains produce toxin TSST-1
- TSST-1 is a "superantigen" encoded by a bacteriophage group 1
- TSST-1 binds to T cell receptor ß2 chains and causes massive T cell stimulation
- Streptococcus [1,6,7]
- Group A streptococcus is a major cause of rheumatic fever, pharyngitis, tonsillitis
- Well documented cause of Toxic Shock Syndrome
- Similar syndromes found in some patients with Group C or G Streptococci [8]
- Group A TSS is caused by non-rheumatogenic strains of S. pyogenes
- These strains are also linked to post-streptococcal glomerulonephritis
- Necrotizing fasciitis, with or without myonecrosis, is present in ~50% of cases
- Group A ß-hemolytic S. pyogenes associated with scarlet fever also described [6]
- The toxin responsible for Groups C or G toxic-shock like syndromes are not known [8]
- Increased risk in American Indians
- Ehrlichia [2]
- Ehrlichiosis can be associated with a toxic-shock-like syndrome
- Usually a benign rickettsial illness with rash and vomiting
C. Staphylococcal TSS
- Fever - often >102°F
- Nausea, Vomiting, Myalgias
- Rash
- Often with mucous membrane involvement
- Desquamation of hands and feet may occur
- Headache, Confusion
- WBC > 15K/µL in ~50% of patients
- Hypotension - quite refractory in many cases
- Hepatitis, Renal Insufficiency, Thrombocytopenia
- Respiratory Distress Syndrome (rare)
D. Streptococcal TSS [1,6,7]
- Isolation of Streptococcus pyogenes (Group A Streptococcus)
- Throat, Sputum, Vagina are most common primary sites
- Blood, CSF, Pleural, Peritoneal Fluid cultures must be obtained
- Blood cultures are often positive
- Groups C and G Streptococcal toxic shock-like syndromes have been described [8]
- Erythematous rash
- Macular
- Maculo-papular
- Presence of necrotizing fasciitis in about 50% of cases
- High fever, increased WBC as above
E. Treatment
- Intensive supportive care is critical
- Antistaphylococcal Antibiotics
- Nafcillin or oxacillin preferred
- Cefazolin may be substituted in penicillin allergic patients
- Added gentamicin or rifampin for 2-3 days may improve bacterial clearance
- Streptococcal TSS
- In animal models, clindamycin appears to be more effective than penicillin
- Use of combination clindamycin + penicillin is suggested [7]
- No toxin-specific assays are currently available for general use
- Drainage of any abscess; removal of infected mechanical devices
- Role of glucocorticoids is unclear
- Intravenous Immune Globulin (IVIg) may be helpful in staphylococcal infections [9]
References
- Working Group on Severe Streptococcal Infections. 1993. JAMA. 269(3):390
- Fichtenbaum CJ, Peterson LR, Weil GJ. 1993. Am J Med. 95(4):351
- Davis JP, Chesney PJ, Wand PJ, et al. 1980. NEJM. 303(25):1429
- Todd J, Fishaut M, Kapral F, Welch T. 1978. Lancet. 2:1116
- Shands KN, Schmid GP, Dan BB, et al. 1980. NEJM. 303(25):1436
- Stevens DL, Tanner MH, Winship J, et al. 1989. NEJM. 321(1):1
- Bisno AL and Stevens DL. 1996. NEJM. 334(4):240
- Hirose Y, Yagi K, Honda H, et al. 1997. Arch Intern Med. 337(16):1891
- Lowy FD. 1998. NEJM. 339(8):520